These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33534976)

  • 21. Current challenges and directions in antithrombotic therapy.
    Van de Werf F
    Timely Top Med Cardiovasc Dis; 2008 Jan; 12():E2. PubMed ID: 18392216
    [No Abstract]   [Full Text] [Related]  

  • 22. The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.
    Hall TS; Atar D
    Eur J Intern Med; 2021 Jun; 88():21-22. PubMed ID: 33934970
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombotic Treatment in Coronary Artery Disease.
    Siasos G; Tsigkou V; Bletsa E; Stampouloglou PK; Oikonomou E; Kalogeras K; Katsarou O; Pesiridis T; Vavuranakis M; Tousoulis D
    Curr Pharm Des; 2023; 29(35):2764-2779. PubMed ID: 37644793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic therapy for patients with chronic coronary syndromes.
    Parker WA; Storey RF
    Heart; 2021 Jun; 107(11):925-933. PubMed ID: 33127651
    [No Abstract]   [Full Text] [Related]  

  • 26. Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).
    Huo Y; Lee SW; Sawhney JP; Kim HS; Krittayaphong R; Nhan VT; Alonso-Garcia A; Han YL; Ge J; Chin CT; Ong TK; Jan S; Itoh Y; Vega AM; Pocock S
    Clin Cardiol; 2015 Sep; 38(9):511-9. PubMed ID: 26206158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endeavours to define optimal antithrombotic therapy after percutaneous coronary intervention.
    Kimura T
    EuroIntervention; 2017 Dec; 13(12):e1386-e1391. PubMed ID: 29208578
    [No Abstract]   [Full Text] [Related]  

  • 28. Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Barbato E; Mehilli J; Sibbing D; Siontis GCM; Collet JP; Thiele H;
    Eur Heart J; 2021 Apr; 42(14):1368-1378. PubMed ID: 32860046
    [No Abstract]   [Full Text] [Related]  

  • 29. Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks.
    Singh M; Bhatt DL; Stone GW; Rihal CS; Gersh BJ; Lennon RJ; Narula J; Fuster V
    Mayo Clin Proc; 2016 Oct; 91(10):1413-1447. PubMed ID: 27712639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 31. Underuse of antithrombotic and antiplatelet treatments for acute coronary syndrome in China: a note of caution.
    Cheng TO
    Chin Med J (Engl); 2009 May; 122(9):1120. PubMed ID: 19493455
    [No Abstract]   [Full Text] [Related]  

  • 32. Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice?
    Cuisset T; Capodanno D
    EuroIntervention; 2018 May; 14(1):19-23. PubMed ID: 29786540
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithrombotic therapy in acute coronary syndromes.
    Watson RD; Chin BS; Lip GY
    BMJ; 2002 Dec; 325(7376):1348-51. PubMed ID: 12468488
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
    Stone GW; Ware JH; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Feit F; Colombo A; McLaurin BT; Cox DA; Manoukian SV; Fahy M; Clayton TC; Mehran R; Pocock SJ;
    JAMA; 2007 Dec; 298(21):2497-506. PubMed ID: 18056903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which heparin and how much?
    Ruchin PE; Labinaz M
    Curr Cardiol Rep; 2008 Jul; 10(4):312-8. PubMed ID: 18611366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome].
    Tubaro M; Falaschi G; Colivicchi F
    G Ital Cardiol (Rome); 2018 Oct; 19(10):552-562. PubMed ID: 30281043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.
    Lane DA; Dagres N; Dan GA; García Seara J; Iliodromitis K; Lenarczyk R; Lip GYH; Mansourati J; Marín F; Scherr D; Potpara TS
    Europace; 2019 Jul; 21(7):1116-1125. PubMed ID: 30874724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute coronary syndromes: advances in antithrombotics.
    Gukathasan N; Mehran R
    Curr Atheroscler Rep; 2013 Apr; 15(4):318. PubMed ID: 23456409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of acute coronary syndrome: the ACUITY trial.
    Mukherjee D; Eagle KA
    Expert Opin Pharmacother; 2009 Feb; 10(3):369-80. PubMed ID: 19191676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antithrombotic therapy in acute coronary syndrome].
    Chazov EI; Panchenko EP
    Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.